Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia

被引:514
作者
Hazan, J [1 ]
Fonknechten, N
Mavel, D
Paternotte, C
Samson, D
Artiguenave, F
Davoine, CS
Cruaud, C
Dürr, A
Wincker, P
Brottier, P
Cattolico, L
Barbe, V
Burgunder, JM
Prud'homme, JF
Brice, A
Fontaine, B
Heilig, R
Weissenbach, J
机构
[1] Genoscope, Evry, France
[2] Fac Med Pitie Salpetriere, INSERM, Paris, France
[3] Federat Neurol, Paris, France
[4] INSERM, U289, Paris, France
[5] Grp Hosp Pitie Salpetriere, F-75634 Paris, France
[6] Univ Spital Bern, Neurol Klin & Poliklin, Bern, Switzerland
[7] Genethon, Evry, France
关键词
D O I
10.1038/15472
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Autosomal dominant hereditary spastic paraplegia (AD-HSP) is a genetically heterogeneous neurodegenerative disorder characterized by progressive spasticity of the lower limbs. Among the four loci causing AD-HSP identified so far, the SPG4 locus at chromosome 2p21-p22 has been shown to account for 40-50% of all AD-HSP families. Using a positional cloning strategy based on obtaining sequence of the entire SPG4 interval, we identified a candidate gene encoding a new member of the AAA protein family, which we named spastin. Sequence analysis of this gene in seven SPG4-linked pedigrees revealed several DNA modifications, including missense, nonsense and splice-site mutations. Both SPG4 and its mouse orthologue were shown to be expressed early and ubiquitously in fetal and adult tissues. The sequence homologies and putative subcellular localization of spastin suggest that this ATPase is involved in the assembly or function of nuclear protein complexes.
引用
收藏
页码:296 / 303
页数:8
相关论文
共 48 条
  • [1] DELETION OF STEROID 5-ALPHA-REDUCTASE 2-GENE IN MALE PSEUDOHERMAPHRODITISM
    ANDERSSON, S
    BERMAN, DM
    JENKINS, EP
    RUSSELL, DW
    [J]. NATURE, 1991, 354 (6349) : 159 - 161
  • [2] Beyer A, 1997, PROTEIN SCI, V6, P2043
  • [3] Prediction of complete gene structures in human genomic DNA
    Burge, C
    Karlin, S
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1997, 268 (01) : 78 - 94
  • [4] Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease
    Casari, G
    De Fusco, M
    Ciarmatori, S
    Zeviani, M
    Mora, M
    Fernandez, P
    De Michele, G
    Filla, A
    Cocozza, S
    Marconi, R
    Dürr, A
    Fontaine, B
    Ballabio, A
    [J]. CELL, 1998, 93 (06) : 973 - 983
  • [5] A 200-AMINO ACID ATPASE MODULE IN SEARCH OF A BASIC FUNCTION
    CONFALONIERI, F
    DUGUET, M
    [J]. BIOESSAYS, 1995, 17 (07) : 639 - 650
  • [6] Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2
    Durr, A
    Davoine, CS
    Paternotte, C
    vonFellenberg, J
    Cogilnicean, S
    Coutinho, P
    Lamy, C
    Bourgeois, S
    Prudhomme, JF
    Penet, C
    Mas, JL
    Burgunder, JM
    Hazan, J
    Weissenbach, J
    Brice, A
    Fontaine, B
    [J]. BRAIN, 1996, 119 : 1487 - 1496
  • [7] Base-calling of automated sequencer traces using phred.: I.: Accuracy assessment
    Ewing, B
    Hillier, L
    Wendl, MC
    Green, P
    [J]. GENOME RESEARCH, 1998, 8 (03): : 175 - 185
  • [8] FINK JK, 1995, AM J HUM GENET, V56, P188
  • [9] Hereditary spastic paraplegia: Advances in genetic research
    Fink, JK
    HeimanPatterson, T
    Bird, T
    Cambi, F
    Dube, MP
    Figlewicz, DA
    Fink, JK
    Haines, JL
    HeimanPatterson, T
    Hentati, A
    PericakVance, MA
    Raskind, W
    Rouleau, GA
    Siddique, T
    [J]. NEUROLOGY, 1996, 46 (06) : 1507 - 1514
  • [10] HARDING AE, 1983, LANCET, V1, P1151